The CAR.MUC1-41BBζ and CAR.MUC1-CD28ζ T cells showed antitumor activity against two MUC1+ cancer cell lines in a dose-dependent manner, indicating a specific antigenic response of the two CAR constructs. Here, MUC1 is linked to cancer.